Regional blood flow alterations after bovine fumaryl ββ-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition

Critical Care Medicine

Volumn 24, Issue 4, 1996, Pages 558-565

  Ulatowski, John A ^a,c   Nishikawa, Toshiaki ^a   Matheson Urbaitis, Barbara ^b   Bucci, Enrico ^b   Traystman, Richard J ^a   Koehler, Raymond C ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

adrenal gland; albumin; blood substitutes; colloid solutions; coronary blood flow; hemoglobin; nitric oxide

Indexed keywords

NITRIC OXIDE SYNTHASE; SERUM ALBUMIN;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CAT; COLLOID; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVITY; ENZYME INHIBITION; EXCHANGE BLOOD TRANSFUSION; HEMOGLOBIN ANALYSIS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ANIMALS; ARGININE; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; CATS; CATTLE; CROSS-LINKING REAGENTS; ENZYME INHIBITORS; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEMOGLOBINS; MICROSPHERES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROSPECTIVE STUDIES; RADIOISOTOPES; RANDOM ALLOCATION; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 0029862605     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199604000-00003     Document Type: Article

References (37)

1. Rabiner SF, Helbert JR, Lopas H, et al: Evaluation of a stroma-free hemoglobin solution for use as a plasma expander. J Exp Med 1967; 126:1127-1142
2. Walder JA, Zaugg RH, Walder RY, et al: Diaspirins that cross-link β chains of hemoglobin: Bis(3,5-dibromosalicyl)-succinate and bis(3,5-dibromosalicyl)-fumarate. Biochemistry 1979; 18:4265-4270
3. Fronticelli C, Sato T, Orth C, et al: Bovine hemoglobin as a potential source of hemoglobin-based oxygen carriers: Crosslinking with bis(3,5-dibromosalycyl)fumarate. Biochim Biophys Acta 1986;874:76-81
4. Snyder SR, Welty EV, Walder RY, et al: HbXL99α: A hemoglobin derivative that is cross-linked between the α subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987; 84:7280-7284
5. Urbaitis BK, Razynska A, Corteza Q, et al: Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. J Lab Clin Med 1991; 117:115-121
6. Sehgal LR, Gould SA, Rosen AL, et al: Polymerized pyridoxylated hemoglobin: A red cell substitute with normal oxygen capacity. Surgery 1984; 95:433-438
7. Rosen AL, Gould SA, Sehgal LR, et al: Effect of hemoglobin solution on compensation to anemia in the erythrocyte-free primate. J Appl Physiol 1990; 68: 938-943
8. Rabinovici R, Rudolph AS, Vernick J, et al: Lyophilized liposome encapsulated hemoglobin: Evaluation of hemodynamic, biochemical, and hematologic responses. Crit Care Med 1994; 22: 480-485
9. Biro GP, Anderson PJ, Curtis SE, et al: Stroma-free hemoglobin: Its presence in plasma does not improve oxygen supply to the resting hindlimb vascular bed of hemodiluted dogs. Can J Physiol Pharmacol 1991; 69:1656-1662
10. Hess JR, MacDonald VW, Brinkley WW: Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74: 1769-1778
11. Van der Plas J, De Vries-Van Rossen A, Bleeker WK, et al: Effect of coupling of 2-nor-2-formylpyridoxal 5′-phosphate to stroma-free hemoglobin on oxygen affinity and tissue oxygenation. Studies in the isolated perfused rat liver under conditions of normoxia and stagnant hypoxia. J Lab Clin Med 1986; 108: 253-260
12. Vogel WM, Dennis RC, Cassidy G, et al: Coronary constrictor effect of stroma-free hemoglobin solutions. Am J Physiol 1986; 251:H413-H420
13. Cole DJ, Schell RM, Przybelski RJ, et al: Focal cerebral ischemia in rats: Effect of hemodilution with α-α cross-linked hemoglobin on CBF. J Cereb Blood Flow Metab 1992; 12:971-976
14. Sharma AC, Gulati A: Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994; 123:299-308
15. Sharma AC, Gulati A: Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23:874-884
16. Imig JD, Gebremedhin D, Harder DR, et al: Modulation of vascular tone in renal microcirculation by erythrocytes: Role of EDRF. Am J Physiol 1993; 264:H190-H195
17. Loeb AL, Longnecker DE: Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am J Physiol 1992; 262:H1494-H1500
18. 2 transport with hematocrit reduced by crosslinked hemoglobin transfusion. Am J Physiol 1996; 270:H466-H475
19. Koehler RC, Traystman RJ, Jones MD Jr: Influence of reduced oxyhemoglobin affinity on cerebrovascular response to hypoxic hypoxia. Am J Physiol 1986; 251:H756-H763
20. Traystman RJ, Moore LE, Helfaer MA, et al: Nitro-L-arginine analogues. Dose-and time-related nitric oxide synthase inhibition in brain. Stroke 1995; 26:864-869
21. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347:768-770
22. Breslow MJ, Tobin JR, Bredt DS, et al: Nitric oxide as a regulator of adrenal blood flow. Am J Physiol 1993; 264: H464-H469
23. Schultz SC, Grady B, Cole F, et al: A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122:301-308
24. Renkin EM, Rew K, Wong M, et al: Influence of saline infusion on blood-tissue albumin transport. Am J Physiol 1989; 257:H525-H533
25. Horn T, Smith PM, McLaughlin BE, et al: Nitric oxide actions in paraventricular nucleus: Cardiovascular and neurochemical implications. Am J Physiol 1994;266:R306-R313
26. Saito S, Kidd GJ, Trapp BD, et al: Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 1994; 59:447-456
27. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res 1992; 70: 607-611
28. Lacolley PJ, Lewis SJ, Brody MJ: Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension 1991; 17:881-887
29. Gulati A, Rebello S: Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med 1994; 124:125-133
30. 2-supply following dextran-haemodilution and methaemoglobinaemia in the dog. Cardiovasc Res 1979; 13:459-468
31. Chapler CK, Cain SM, Stainsby WN: Blood flow and oxygen uptake in isolated canine skeletal muscle during acute anemia. J Appl Physiol 1979; 46:1035-1038
32. Majid DSA, Navar LG: Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney. Am J Physiol 1992; 262:F40-F46
33. Salom MG, Lahera V, Miranda-Guardiola F, et al: Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol 1992; 262:F718-F722
34. Sigmon DH, Carretero OA, Beierwaltes WH: Endothelium-derived relaxing factor regulates renin release in vivo. Am J Physiol 1992; 262:F256-F261
35. Bleeker WK, Van der Plas J, Agterberg J, et al: Prolonged vascular retention of a hemoglobin solution modified by cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J Lab Clin Med 1986; 108: 448-455
36. Hughes G Jr, Jacobs E Jr, Antal E, et al: Pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Abstr. Crit Care Med 1995; 23(Suppl): A257
37. Bleeker WK, Van der Plas J, Feitsma RIJ, et al: In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J Lab Clin Med 1989; 113:151-161